Skip to main content
Fig. 1 | Journal of Neuroinflammation

Fig. 1

From: Isotalatizidine, a C19-diterpenoid alkaloid, attenuates chronic neuropathic pain through stimulating ERK/CREB signaling pathway-mediated microglial dynorphin A expression

Fig. 1

The effect of isotalatizidine on acetic acid-induced somatic pain in mice. (a) The chemical structure of isotalatizidine. Isotalatizidine significantly decreased the writhing times (b) and increased the rate of analgesia (c) in acetic acid-induced mice. The ED50 of analgesic efficiency of isotalatizidine was 0.43 mg/kg (d). Data are expressed as mean ± SEM (n = 8 mice in each group). *P < 0.05, **P < 0.01, ***P < 0.001 vs. vehicle group

Back to article page